Purchase Order 75F40122P00312

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $14,655.20 on June 4, 2020, to procure a SpectraMax ABS Plus UV/Vis single-mode microplate reader. Place of performance is San Jose, California. The order carries firm fixed price terms and was due for completion by July 3, 2020. No set-aside designation applied.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Molecular Devices LLC for a SpectraMax M2E microplate reader at $26,774.19 with an award date of July 15, 2015 and ultimate completion date of July 14, 2016. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside category. Molecular Devices is a San Jose–based subsidiary of Beckman Coulter (itself owned by Danaher Corporation) and manufactures specialized bioanalytical laboratory...

<p>The National Heart Lung and Blood Institute issued a purchase order to Molecular Devices LLC for a SpectraMax ID3 multi-mode microplate reader valued at $30,343.10, awarded August 31, 2020, with a performance deadline of September 30, 2020. Work is performed at the vendor's facility in San Jose, California. The order is firm fixed price with no small business set-aside. The underlying opportunity was posted August 18, 2020 with a due date of August 25, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $92,701.00 on July 10, 2026, for a SpectraMax M3 upgradable microplate/cuvette reader. The award is firm fixed price with no set-aside category. Place of performance is San Jose, California. Ultimate completion date is August 10, 2026.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $28,202.00 on June 21, 2018, for the purchase of a SpectraMax Plus 384 plate reader. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of July 13, 2018. No set-aside was used.</p>

Molecular Devices LLC, a San Jose, California-based subsidiary of Danaher Corporation, was awarded a $28,624 firm fixed-price purchase order by the Pacific West Area civilian federal agency on September 27, 2019, for a SpectraMax ID3 multi-mode microplate detection platform system. The contract, which carried no set-aside designation, was to be completed by November 30, 2019, with performance taking place at the contractor's San Jose facility. The solicitation was posted on September 23, 2019,...

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17 awarded a purchase order to Molecular Devices LLC for $55,338.50 on September 1, 2026 for a SpectraMax iD5e MultiMode Microplate Reader. Ultimate completion is October 31, 2026. The instrument will be delivered to San Jose, California and deployed at the VISN 17 Center of Excellence in Waco, Texas to support biochemical, cellular, and molecular research assays. The SpectraMax iD5e provides five...

This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to VWR International LLC. The $18,771.69 contract is for the purchase of a SpectraMax ABS Plus microplate reader, which is a laboratory instrument used for optical detection and analysis. This award is made under VWR's existing Multiple Award Schedule (MAS) contract, a government-wide acquisition vehicle. The order has an ultimate completion date of October...

This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,168.70 firm fixed-price purchase order to Molecular Devices LLC for a SPECTRAMAX MICROPLATE READER (AMBIS #2183390). Performance will take place in San Jose, California over a period of approximately four months concluding in late December 2023. As part of its mission to conduct and support medical research, the funding agency likely requires the...